Search for: "Janssen Pharmaceuticals Inc." Results 161 - 180 of 244
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
3 Oct 2011, 9:28 pm by Barry Barnett
Ortho-McNeil-Janssen Pharmaceuticals, Inc., No. 11-2070 (7th Cir. [read post]
12 Aug 2011, 5:00 am
Complera™ combines Gilead's Truvada®, a fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, and Tibotec Pharmaceuticals' rilpivirdine (marketed in the United States by Janssen Therapeutics as Edurant™). [read post]
8 Aug 2011, 12:53 pm by info@thomasjhenrylaw.com
Violations of this act have led to multi-million dollar settlements with other pharmaceutical giants like Eli Lilly and Co. and Pfizer Inc. in the past. [read post]
20 Jul 2011, 1:27 pm by Bexis
Janssen Pharmaceuticals, Inc., 2011 WL 2640801, slip op. [read post]
7 Jul 2011, 10:00 am by Lucas A. Ferrara, Esq.
.- based Janssen Pharmaceuticals, Inc., a member of the Janssen Pharmaceutical Companies of Johnson & Johnson. [read post]
5 Jul 2011, 11:13 pm
One of J&J's lawyers said, “The jury took a good, hard look at all the evidence and correctly concluded that Ortho-McNeil-Janssen Pharmaceuticals, Inc. acted responsibly and properly in disclosing the risks associated with this effective and life-saving medicine. [read post]
21 Jun 2011, 6:00 am by Mark Zamora
Ortho-McNeil-Janssen Pharmaceuticals Inc. announced that the lot of about 16,000 bottles of 3-milligram Risperdal tablets was shipped out anywhere from August, 2010  and February, 2011. [read post]
20 Jun 2011, 7:47 am by info@thomasjhenrylaw.com
Ortho-McNeil-Janssen Pharmaceuticals, Inc., a member of the Johnson and Johnson family, has issued a recall of about 40,000 bottles of Risperdal and its generic form. [read post]
13 Jun 2011, 5:32 pm by FDABlog HPM
Paliperidone FDA approved INVEGA on December 19, 2006 under NDA No. 21-999 and granted the sponsor, Ortho-McNeil-Janssen Pharmaceuticals, Inc. [read post]
2 Jun 2011, 12:46 pm by Bexis
Ortho Pharmaceutical Corp., 681 P.2d 1038, 1052 (Kan. 1984). [read post]
23 May 2011, 9:59 pm by Patent Docs
Impax Laboratories, Inc. et al. 1:11-cv-00395; filed May 5, 2011 in the District Court of Delaware • Plaintiffs: Alza Corp.; Ortho-McNeil-Janssen Pharmaceuticals, Inc. [read post]
4 May 2011, 7:52 am by Tron Emptage
Brand Name Opioid Products Generic Name Trade Name Applicant/Sponsors Fentanyl Duragesic Extended Release Transdermal System Ortho McNeil Janssen Hydromorphone *Palladone Extended Release Capsules Purdue Pharma   Methadone Dolophine Tablets Roxanne Morphine Avinza® Extended Release Capsules King Pharms   Morphine Kadian® Extended Release Capsules Actavis   Morphine MS Contin Extended Release Tablets Purdue Pharma… [read post]
28 Apr 2011, 3:18 pm by Bexis
By now Restatement (Second) of Torts §402A (1965) is so old as to be thought of as somewhat antediluvian. [read post]
18 Apr 2011, 1:12 pm by Mark Zamora
Ortho-McNeil Neurologics Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., today announced it is voluntarily recalling two lots of TOPAMAX® (topiramate) 100mg Tablets. [read post]
18 Apr 2011, 12:40 pm by Tom Lamb
Warnings Increased About Risk Of Side Effects Like Pulmonary Embolism (PE) And Deep Vein Thrombosis (DVT) (Posted by Tom Lamb at DrugInjuryWatch.com)In March 2011 Ortho-McNeil-Janssen Pharmaceuticals, Inc. revised the Prescribing Information (more commonly called the "package insert" or "label") for its Ortho Evra (norelgestromin/ ethinyl estradiol) transdermal system to give a stronger warning about blood clot related side effects like pulmonary… [read post]
24 Feb 2011, 1:49 pm by Bexis
Janssen Pharmaceutica, Inc., 2006 WL 3665417, at *4 n.2 (S.D. [read post]